Drawing based on the label description. No photo yet.
a15 pill
Pill with imprint a15 is purple, oval, 14 mm and has been identified as Upadacitinib 15 mg. It is supplied by Abbvie Inc.
Upadacitinib 15 mg
- Imprint
- a15
- Strength
- 15 mg
- Color
- Purple
- Shape
- Oval
- Size
- 14 mm
- Score
- No score line
- Form
- Tablet, extended release
- Manufacturer
- Abbvie Inc
- NDC
- 0074-2306, 0074-2306-30, 0074-2306-70
Is this your pill? Check every detail
- The imprint reads exactly a15, on the same sides.
- It is purple, oval, 14 mm.
- The score line, coating and any logo match the photo.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Rinvoq.
Ingredients
Active: Upadacitinib
Inactive: Silicon Dioxide, Ferrosoferric Oxide, Hypromellose, Unspecified, Ferric Oxide Red, Magnesium Stearate, Mannitol, Microcrystalline Cellulose, Polyvinyl Alcohol, Unspecified, Polyethylene Glycol, Unspecified, Talc, Tartaric Acid, Titanium Dioxide
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
- 5 Sonrotoclax 5 mg Purple, oval, 14 mm
- V10 Vanzacaftor, Tezacaftor, and Deutivacaftor 10 mg / 50 mg / 125 mg Purple, oval, 15 mm
- u75 Brivaracetam 75 mg Purple, oval, 13 mm Schedule V
- IT 75 Brivaracetam 75 mg Purple, oval, 13 mm Schedule V
- b 945 15 Methotrexate 15 mg Purple, oval, 15 mm
- G 391 Carbidopa and Levodopa 50 mg / 200 mg Purple, oval, 13 mm
Other Upadacitinib pills
- a30 Upadacitinib 30 mg Red, oval, 14 mm
- a45 Upadacitinib 45 mg Yellow, oval, 14 mm
- No picture yet DIN 02495155 Upadacitinib 15 mg Rinvoq, Tablet (extended-release), sold in Canada
- No picture yet DIN 02520893 Upadacitinib 30 mg Rinvoq, Tablet (extended-release), sold in Canada
- No picture yet DIN 02539721 Upadacitinib 45 mg Rinvoq, Tablet (extended-release), sold in Canada